HD Labs | Hybrid Compound Peptide 44mg (Tirsema) | Compound Peptide Pen
Advanced Multi-Pathway Metabolic Research Compound
HD Labs Tirsema 44mg is an investigational hybrid peptide research compound studied in laboratory environments for its role in multi-receptor metabolic signalling pathways, energy regulation mechanisms, and endocrine communication systems.
Hybrid peptide formulations are widely referenced in scientific research exploring glucose homeostasis, insulin signalling networks, and appetite regulation pathways within controlled experimental models.
Developed as a 44mg compound peptide pen, this formulation is designed for laboratory preparation and controlled research applications where multi-pathway metabolic signalling and peptide interaction studies are of scientific interest.
HD Labs Tirsema 44mg Hybrid Compound Peptide Pen
• Hybrid peptide research compound studied in metabolic signalling models
• Investigated in multi-receptor endocrine communication pathways
• Of interest in glucose regulation and insulin response research
• Explored in appetite control and energy balance studies
• 44mg pen format designed for laboratory preparation use
• High-purity investigational formulation from HD Labs
• Manufactured for stability, consistency, and research reliability
• Strictly intended for laboratory research use only
⚖️ DISCLAIMER
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
